240
staff
William Lee
William (Bill) Lee is chief economist at the Milken Institute.
report
Global Opportunity Index 2022: White Paper
The Global Opportunity Index assesses countries' attractiveness to international investors using a
combination of economic, financial, institutional, and regulatory factors.
+ Read More
report
Global Opportunity Index 2022: Focus on Emerging Southeast Asia
This report uses the 2022 Global Opportunity Index (GOI) and its various categories to examine the
attractiveness of emerging Southeast Asia as a foreign investment destination—especially when compared to other emerging markets and developing economies
+ Read More
report
Scaling Comprehensive Dementia-Care Models
Despite scientific progress over the past 25 years, dementia remains one of the toughest health-car
e challenges.
+ Read More
report
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes t
o mind. However, technology and devices are proving to be valuable options for treating intractable illnesses.
+ Read More
report
Alzheimer's Disease - A Giving Smarter Guide
Alzheimer’s disease is increasingly in the spotlight after a number of high-profile clinical trial
failures—an alarming trend as an estimated 5.5 million adult Americans live with this disease, which disproportionally affects the aged population.
+ Read More
report
Bahrain and the Fourth Industrial Revolution
Bahrain differentiates itself from its larger neighbors by highlighting its well-trained population
and low cost of living and running a business.
+ Read More
report
Framing the Issues: De-Risking and Its Consequences for Global Commerce and the Financial System
On March 4, 2015, the Milken Institute Center for Financial Markets hosted a day-long roundtable,&n
bsp;Framing the Issues: De-Risking and Its Consequences for Global Commerce and the Financial System, with AML/CFT policymakers, regulators, fina
+ Read More
report
Alzheimer's Disease: A Giving Smarter Guide to Accelerate Development of New Therapies
The need is staggering. Alzheimer's disease is the sixth leading cause of death in the United State
s and currently, more than 5.5 million Americans are living with this disease for which there is yet no cure yet.
+ Read More
report
Financial Deregulation: Repeal or Adjust?
While a major overhaul of U.S. financial regulation may be unlikely during the early months of the
Trump administration, changes should be expected as his nominees to lead the Treasury Department and financial regulatory agencies are confirmed.
+ Read More
report
Macroprudential Policy: Silver Bullet or Refighting the Last War?
In the wake of the global financial crisis, policymakers, investors, and lenders analyzed the lead-
up to the meltdown to see what changes could prevent another near-collapse.
+ Read More
report
Trade Finance: A Catalyst for Growth in Asia
While large businesses have resumed international trade at levels seen before the financial crisis,
small- and medium-sized enterprises (SMEs) have not fared as well.
+ Read More